Thursday, January 31, 2019

Sosei Heptares to Launch ORAVI® Mucoadhesive Tablets 50mg for Oropharyngeal Candidiasis in Japan

TOKYO and LONDON, January 31, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565), announces its wholly-owned Japanese subsidiary Sosei Co., Ltd. ("the Business"), will launch ORAVI® Mucoadhesive Tablets 50mg in Japan on 4 February 2019. ORAVI® is a novel once-daily...



from PR Newswire: https://prn.to/2G0EqJ3

No comments:

Post a Comment